CV 2 antibodies / CRMP5 protein
The test is primarily used to identify neurological symptoms caused by paraneoplastic syndromes, which are often linked to an underlying cancer.
Common cancers associated with CV2 antibodies include small-cell lung cancer (SCLC) and thymomas.